Oncolinx Pharmaceuticals, LLC — Form D
Oncolinx Pharmaceuticals, LLC of Boston, MA, a company, filed a Form D exempt-offering notice with the SEC on 2014-12-30. The offering totals $1.0M, of which $350K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2014-12-30
- Form: D
- Accession: 0000897069-14-000500
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $350K
- Remaining: $650K
- Investors: 1
- Date of first sale: 2014-10-31
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-231043
Issuer
- Name: Oncolinx Pharmaceuticals, LLC
- CIK: 0001627422
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: MassChallenge, Attn: Oncolinx, Boston, MA, 02210
- Phone: (848) 391-9367
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Riley Ennis | Director | South San Francsico, CA |
| Sourav Sinha | Director | Boston, MA |
| Riley Ennis | Executive Officer | South San Francsico, CA |
| Sourav Sinha | Executive Officer | Boston, MA |
| Riley Ennis | Promoter | South San Francsico, CA |
| Sourav Sinha | Promoter | Boston, MA |
More